Seizure outcome trajectories in a well‐defined cohort of newly diagnosed juvenile myoclonic epilepsy patients
Acta Neurologica Scandinavica Nov 23, 2021
Irelli EC, Morano A, Orlando B, et al. - A cohort of juvenile myoclonic epilepsy (JME) patients was examined over a long-term follow-up in order to report in the temporal course of medication response and linked prognostic factors in this cohort.
Retrospective review of data from 113 JME patients diagnosed according to recently proposed class II criteria.
Seventy-six of 113 (67.3%) individuals obtained 4-year seizure remission; 45/76 (59.2%) patients showed achievement of early sustained remission.
Multivariable multinomial logistic regression analysis revealed significant correlation of absence seizures with no-remission.
Delayed sustained remission was observed in significant correlation with presence of catamenial seizures and earlier age at epilepsy onset.
15.7% of patients with early sustained remission and 35.5% of those with delayed sustained remission showed spontaneous seizure relapse after 4-year remission.
Irregular lifestyle habits and pregnancy-related switch from valproate to another ASM were identified to be the most common concomitant factors for a spontaneous relapse.
At univariable analysis, more frequent occurrence of a spontaneous generalized tonic-clonic seizure relapse was recorded after 4-year remission among patients with a history of catamenial seizures.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries